Medicines that matter: Biohaven’s Nurtec™ drug development journey Case Study 重塑医药未来:Biohaven 公司 Nurtec™ 药物的研发之旅 In February 2020, Biohaven Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) approved…webdev2024 年 8 月 15 日
Certification Courses Pricing and Discounts Announcement Certara 认证课程定价与折扣 Certara University offers 3 Introductory level Certification Courses. These courses are administered within the learning…webdev2023 年 10 月 27 日
VIVD: Virtual in vitro distribution model for the mechanistic prediction of intracellular concentrations of chemicals in in vitro toxicity assays Publication VIVD: Virtual in vitro distribution model for the mechanistic prediction of intracellular concentrations of chemicals in in vitro toxicity assays webdev2020 年 6 月 28 日
The Rare Disease Drug Dilemma: Great Value, High Price, Limited Access? 网络研讨会点播 罕见病药物困境:价值大、价格高、准入受限? This webinar will explain how pricing has evolved for the rare disease drug market and…webdev2020 年 2 月 19 日
How to Demonstrate Virtual Bioequivalence for Complex Dermal Generic Drugs On-Demand Webinar 如何证明复杂皮肤仿制药的虚拟生物等效性 This webinar will explain how Certara expanded its PBPK Simcyp Simulator to incorporate an extensive…webdev2020 年 1 月 24 日
Visualization of Complex Trial Data in Non-Linear Mixed-Effect Analyses With Covariates Poster Visualization of Complex Trial Data in Non-Linear Mixed-Effect Analyses With Covariates webdev2020 年 1 月 17 日
Use of Modeling and Simulations to Determine Raltegravir Dosing in Neonates: A Model for Safely and Efficiently Determining Appropriate Neonatal Dosing Regimens: IMPAACT P1110 Publication Use of Modeling and Simulations to Determine Raltegravir Dosing in Neonates: A Model for Safely and Efficiently Determining Appropriate Neonatal Dosing Regimens: IMPAACT P1110 webdev2020 年 1 月 17 日
Maternal-Neonatal Raltegravir Population Pharmacokinetics Modeling: Implications for Initial Neonatal Dosing Publication Maternal-Neonatal Raltegravir Population Pharmacokinetics Modeling: Implications for Initial Neonatal Dosing Maternal-Neonatal Raltegravir Population Pharmacokinetics Modeling: Implications for Initial Neonatal Dosingwebdev2020 年 1 月 17 日
Predicting Human Oral Bioavailability: Comparison of In Vivo Animal (Rat- Dog- and Monkey) Studies versus Mechanistic In Vitro In Vivo Extrapolation (IVIVE) Based Predictions Poster Predicting Human Oral Bioavailability: Comparison of In Vivo Animal (Rat- Dog- and Monkey) Studies versus Mechanistic In Vitro In Vivo Extrapolation (IVIVE) Based Predictions webdev2019 年 11 月 6 日
Fitting PBPK Model Parameters within Simcyp Engine Using Simcyp-R Package Poster Fitting PBPK Model Parameters within Simcyp Engine Using Simcyp-R Package webdev2019 年 11 月 6 日